Literature DB >> 8807570

Production of hyaluronan by glomerular mesangial cells in response to fibronectin and platelet-derived growth factor.

M E Dunlop1, S Clark, P Mahadevan, E Muggli, R G Larkins.   

Abstract

The formation of the non-sulphated glycosaminoglycan hyaluronan by cells of the renal glomerulus in diabetes may contribute to altered matrix composition. We describe an increased production of hyaluronan from mesangial cell-enriched glomerular cores from diabetic animals, and further show that increased hyaluronan production follows the exposure of non-diabetic and diabetic preparations to fibronectin and to platelet-derived growth factor in vitro. Hyaluronan production appeared dependent on protein kinase C activity, and could not be shown after prolonged phorbol ester preincubation. Stimulation by fibronectin was wholly dependent on cyclooxygenase activity and prior prostaglandin production, while the effect of platelet-derived growth factor showed only a partial dependence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807570     DOI: 10.1038/ki.1996.284

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.

Authors:  Aimin Wang; Juan Ren; Christina P Wang; Vincent C Hascall
Journal:  J Biol Chem       Date:  2014-01-30       Impact factor: 5.157

2.  Heparin affects cytosolic glucose responses of hyperglycemic dividing mesangial cells.

Authors:  Andrew Jun Wang; Juan Ren; Amina Abbadi; Aimin Wang; Vincent C Hascall
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

3.  Hyaluronan induces the selective accumulation of matrix- and cell-associated proteoglycans by mesangial cells.

Authors:  Sabine Kastner; Gareth J Thomas; Robert H Jenkins; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2007-11-01       Impact factor: 4.307

4.  Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3.

Authors:  Kirsi Rilla; Sanna Oikari; Tiina A Jokela; Juha M T Hyttinen; Riikka Kärnä; Raija H Tammi; Markku I Tammi
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

Review 5.  The role of renal proximal tubular cells in diabetic nephropathy.

Authors:  Aled O Phillips
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

6.  Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.

Authors:  Sara Stridh; Fredrik Palm; Tomoko Takahashi; Mayumi Ikegami-Kawai; Peter Hansell
Journal:  Ups J Med Sci       Date:  2015-07-14       Impact factor: 2.384

Review 7.  Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.

Authors:  Sophie Dogné; Bruno Flamion; Nathalie Caron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06-07       Impact factor: 8.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.